| Not Yet Recruiting | Use of Intranasal Midazolam to Reduce Stress and Procedural Pain in Premature Infants During Routine ROP Exami NCT06889376 | Polish Mother Memorial Hospital Research Institute | Phase 1 |
| Recruiting | Efficacy and Safety of Fospropofol in Adult Laparoscopic Surgery: A Clinical Trial NCT06573489 | Hui Xu | Phase 4 |
| Completed | Pharmacokinetic Study of Cefditoren Pivoxil in Breast Milk and Blood of Lactating Women NCT06644105 | West China Second University Hospital | N/A |
| Unknown | Ascending Single-Dose and Multiple-Dose Study to Evaluate RJ4287 in Healthy Subjects NCT05921006 | Nanjing Ruijie Pharma Co., Ltd. | Phase 1 |
| Unknown | Comparison of PSORI-CM01 Formula vs Gu Ben Hua Yu Formula Combined With AD-MSCs in Psoriasis NCT04785027 | Guangdong Provincial Hospital of Traditional Chinese Medicine | Phase 1 / Phase 2 |
| Terminated | An Assessment of the Safety and Pharmacokinetics of Ascending Doses of SANGUINATE™ in Healthy Volunteers. NCT01847222 | Prolong Pharmaceuticals | Phase 1 |
| Completed | Reducing Medication Errors on Basis of an Individual Risk Assessment NCT01814280 | University of Aarhus | N/A |
| Active Not Recruiting | Reducing and Removing Hyaluronic Acid Filler With Hyaluronidase NCT01722916 | Northwestern University | EARLY_Phase 1 |
| Completed | Safety and Preliminary Efficacy Study of the Antibody PAT-SM6 in Patients With Relapsed or Refractory Multiple NCT01727778 | Patrys Ltd. | Phase 1 |
| Completed | Data-driven Quality Improvement in Primary Care - Trial NCT01425502 | University of Dundee | N/A |
| Completed | Safety and Tolerability of Namisol in the Elderly NCT01740960 | Radboud University Medical Center | Phase 1 |
| Completed | Pharmacokinetics of Ceftaroline in Normal and Obese Subjects NCT01648127 | Keith A. Rodvold | Phase 1 |
| Unknown | Therapeutic Effect and Safety Study of Decitabine in Elderly Acute Myeloid Leukemia Patients NCT01633099 | Jianxiang Wang | Phase 3 |
| Completed | Efficacy and Safety Study of Dexmedetomidine as an Additive to Local Anesthetics in Shoulder Surgery NCT01557270 | Prof. Peter Gerner, M.D. | Phase 3 |
| Completed | A Trial to Assess the Safety, Tolerability and Pharmacokinetics of MDT-637 in Subjects With Intermittent, or M NCT01556607 | MicroDose Therapeutx, Inc | Phase 1 |
| Unknown | Efficacy of Ascorbic Acid for Prevention of Colistin-Associated Nephrotoxicity NCT01501968 | Mahidol University | Phase 3 |
| Completed | Ascending Multiple-Dose Study to Evaluate VIA-3196 in Healthy Subjects NCT01519531 | Madrigal Pharmaceuticals, Inc. | Phase 1 |
| Unknown | Probiotics for Prevention of Ventilator-Associated Pneumonia (VAP) NCT01301131 | Mahidol University | Phase 4 |
| Completed | A Trial to Assess the Safety, Tolerability and Pharmacokinetics of MDT-637 in Healthy Volunteers NCT01489306 | MicroDose Therapeutx, Inc | Phase 1 |
| Completed | Comparing Patient Comfort and Safety Between Iodixanol and Iopamidol in Patients Undergoing Peripheral Arterio NCT01475097 | GE Healthcare | Phase 4 |
| Completed | A Trial to Assess the Safety, Tolerability, and Pharmacokinetics of MDT-637 in Healthy Volunteers NCT01355016 | MicroDose Therapeutx, Inc | Phase 1 |
| Unknown | Exploratory Study on the S-1 + Paclitaxel Chemotherapy for Unresectable Gastric Cancer NCT01756183 | Zhejiang Cancer Hospital | Phase 2 |
| Completed | Safety and Pharmacokinetics Study of CARD-024 in Healthy Subjects NCT01757860 | Cardiavent Inc. | Phase 1 |
| Completed | Evaluation of Liposomal Curcumin in Healthy Volunteers NCT01403545 | SignPath Pharma, Inc. | Phase 1 |
| Completed | A Three Stage, Study to Assess the Safety, Pharmacokinetics and Pharmacodynamics of Oral PTH (1-34) in Healthy NCT02202603 | Entera Bio Ltd. | Phase 1 |
| Completed | Ascending Single-Dose Study to Evaluate VIA-3196 in Healthy Subjects NCT01367873 | Madrigal Pharmaceuticals, Inc. | Phase 1 |
| Completed | Safety, Immunogenicity and Dose Response of ATH03, a New Vaccine Against the Cholesterol Ester Transfer Protei NCT01284582 | Affiris AG | Phase 1 |
| Unknown | Ertapenem Versus Meropenem/Imipenem for ESBL+ Gram-negative Infections NCT01297842 | Mahidol University | Phase 4 |
| Completed | Clinical Assessment of Safety and Tolerability of the New Monoclonal Humanized Antibody CaCP29 NCT01319903 | InflaRx GmbH | Phase 1 |
| Unknown | Colistin Plus Rifampicin in MDR P. Aeruginosa and A. Baumanii NCT01297855 | Mahidol University | Phase 3 |
| Unknown | Colistin Versus Colistin Plus Fosfomycin for Infections Caused by MDR Acinetobacter Baumannii NCT01297894 | Mahidol University | Phase 3 |
| Completed | A Study to Assess the Efficacy and Safety of Fospropofol Disodium NCT01271569 | West China Hospital | Phase 1 |
| Completed | Remegal Different Doses in Patients With Refractory Partial Seizures NCT01179854 | Valexfarm | Phase 2 |
| Completed | Pharmacy Based Pharmacoepidemiological Observational Study With Aspirin Protect 100 mg NCT01669824 | Bayer | — |
| Completed | Clinical Safety of a Novel Milk Protein Peptide NCT01412658 | Ambryx Biotechnology | Phase 1 |
| Completed | A Safety Study of Lessertia Frutescens in Adults. NCT00376415 | University of Missouri-Columbia | Phase 1 |